Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls.

Milena Casula, Mauro Alaibac, Maria A. Pizzichetta, Riccardo Bono, Paolo A. Ascierto, Ignazio Stanganelli, Sergio Canzanella, Grazia Palomba, Edoardo Zattra, Giuseppe Palmieri

Research output: Contribution to journalArticle

Abstract

BACKGROUND: A single nucleotide polymorphism (61A>G) in the epidermal growth factor (EGF) gene has been implicated in both melanoma pathogenesis and increased melanoma risk. To further evaluate this association, we conducted a case-control study in a clinic-based Italian population. METHODS: Individuals with less than 10 (N = 127) or more than 100 (N = 128) benign nevi, and patients with cutaneous melanoma (N = 418) were investigated for the EGF +61A>G polymorphism, using an automated sequencing approach. RESULTS: Overall, no difference in EGF genotype frequencies was observed among subjects with different number of nevi as well as when non-melanoma healthy controls were compared with the melanoma patients. However, a heterogeneous distribution of the frequencies of the G/G genotype was detected among cases and controls originating from North Italy (21.1 and 18.3%, respectively) vs. those from South Italy (12.6 and 17.1%, respectively). CONCLUSION: Our findings further suggest that EGF +61A>G polymorphism may have a limited impact on predisposition and/or pathogenesis of melanoma and its prevalence may vary in different populations.

Original languageEnglish
Pages (from-to)7
Number of pages1
JournalBMC Dermatology
Volume9
DOIs
Publication statusPublished - 2009

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls.'. Together they form a unique fingerprint.

  • Cite this